Three years of treatment with Ingrezza (valbenazine) led to rapid and sustained reductions in the severity of uncontrolled movements known as chorea for people with Huntington’s disease. That’s according to […] The post Three years of Ingrezza treatment reduces chorea severity in HD appeared first on Huntington's Disease News.
